- Home
- TXG vs ASST Comparison
TXG vs ASST Comparison
Compare TXG & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- ASST
- Stock Information
- Founded
- TXG 2012
- ASST 2020
- Country
- TXG United States
- ASST United States
- Employees
- TXG N/A
- ASST N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- ASST Computer Software: Prepackaged Software
- Sector
- TXG Industrials
- ASST Technology
- Exchange
- TXG Nasdaq
- ASST Nasdaq
- Market Cap
- TXG 1.6B
- ASST 1.7B
- IPO Year
- TXG 2019
- ASST 2023
- Fundamental
- Price
- TXG $15.93
- ASST $1.08
- Analyst Decision
- TXG Buy
- ASST
- Analyst Count
- TXG 13
- ASST 0
- Target Price
- TXG $14.50
- ASST N/A
- AVG Volume (30 Days)
- TXG 3.2M
- ASST 190.7M
- Earning Date
- TXG 11-06-2025
- ASST 11-14-2025
- Dividend Yield
- TXG N/A
- ASST N/A
- EPS Growth
- TXG N/A
- ASST N/A
- EPS
- TXG N/A
- ASST N/A
- Revenue
- TXG $641,814,000.00
- ASST $4,953,567.00
- Revenue This Year
- TXG $2.07
- ASST N/A
- Revenue Next Year
- TXG N/A
- ASST N/A
- P/E Ratio
- TXG N/A
- ASST N/A
- Revenue Growth
- TXG 1.92
- ASST 49.00
- 52 Week Low
- TXG $6.78
- ASST $0.34
- 52 Week High
- TXG $17.70
- ASST $13.42
- Technical
- Relative Strength Index (RSI)
- TXG 62.12
- ASST 37.20
- Support Level
- TXG $12.80
- ASST $1.30
- Resistance Level
- TXG $17.70
- ASST $1.72
- Average True Range (ATR)
- TXG 0.97
- ASST 0.22
- MACD
- TXG 0.30
- ASST 0.08
- Stochastic Oscillator
- TXG 66.79
- ASST 3.78
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About ASST Asset Entities Inc. Class B
Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.